Registered title, quoted from ClinicalTrials.gov
Endoscopic Submucosal Dissection Versus Surgery in the Treatment of Early Gastric Cancer
An open trial on stomach cancer, registered on ClinicalTrials.gov. Led by Peking University Third Hospital; 0 other hospitals on this site are listed as study sites.
Status, phase and start date as registered on ClinicalTrials.gov on 8 Nov 2026; the registry may have changed since. Whether someone can take part is decided by the study team. Not medical advice.
The study team’s contact details are on the registry record. This site does not pass on enquiries.
Hospitals in mainland China listed for this trial 1
Hospitals on this site that the registry record names as lead sponsor or study site, where the site is open. Lead sponsor first, then study sites A–Z.
The record may name more sites, including outside mainland China, and sites can open or close during a trial. Full list of sites on ClinicalTrials.gov
Source: ClinicalTrials.gov record NCT03857737, read on 8 Nov 2026; hospital names matched to this site’s hospital list. How names are matched
Registered criteria
Quoted as registered on ClinicalTrials.gov, in English, read on 10 Nov 2026. This site has not checked, shortened or translated them. Meeting the written criteria is not enough: the study team decides after its own screening.
Inclusion Criteria:
- Clinically diagnosed as early gastric cancer
- Willing to undergo endoscopic submucosal dissection or surgery for the treatment of early gastric cancer
Exclusion Criteria:
- Advanced stage gastric cancer
- Not willing to undergo endoscopic submucosal dissection or surgery for the treatment of early gastric cancer
- Not willing to participate in this study
Quoted from ClinicalTrials.gov, NCT03857737, participation criteria. Read on 10 Nov 2026.
Where this information comes from
The registry record
ClinicalTrials.gov (US National Library of Medicine), record NCT03857737, read on 8 Nov 2026. A trial has a page here while its overall status is recruiting, not yet recruiting or enrolling by invitation and at least one listed hospital’s site is open. Trials registered only in China’s own registry (ChiCTR) are not included.
Diseases and hospitals
The trial is listed under a disease when this site’s ClinicalTrials.gov search for that disease in China returns it. Sponsor and site names in the record are matched to this site’s hospital list (ROR identifiers, checked aliases). Definitions
What is left out
Names of investigators and contact persons in the record, and anything not in the record. The title and criteria are quoted from the record.